לונג
Mind Medicine MMEDF
מעודכן
MMEDF (MIND MEDICINE)
Mind Medicine- Just to share a brief break down of what this company actually does. They are a research & drug development company focusing on LSD, Psilocybin, MDMA and a few other experimental drugs, CEO JR Rahn, Board of Directors Bruce Linton ( EX Canopy Founder) & Investors including Kevin O'leery AKA the dream team (just kidding).
Two major reasons behind the spike/growth in stock price. 1) They have submitted an application for an up listing onto the Nasdaq. 2) Compass Pathways also a Psilocybin company has IPO'd in the previous weeks & had been received very well by the markets/investors. Side Note: Marking a new wave of stocks of its kind (Shroom Boom)
Moving Forward: Since they are still in the drug & development stage, their financials are somewhat non-existent, so its quite difficult to put a price on this stock, but as we well all know markets are forward looking & the potential upside for this company could be exponential. Reason behind the logic for exponential growth is their drug pipeline, which is in the process of FDA approval, they currently have +5 drugs in the FDA approval process & with the shift into experimental drugs & their use in treating depression, anxiety, ADHD, PTSD, which in total is around a 100 billion dollar market. In simpler terms, the potential is there & the upside is there. Main question is: Will they get FDA approval for any of these 5 drugs in the pipeline? We have yet to wait & see. However, once they do up list onto the nasdaq expect to see average of a 20% surge in market prices.
Investment Decision: BUY, it is important to note than Mr.Benjamin Gram even once said keep 10-20% (depending how risk averse you are) in speculative positions. As a speculative buy, in my personal opinion this stock & the future potential that it may have in store for us is worth the buy. All it would take is one drug to be FDA approved. Even Amazon was once considered speculative.........
Target Price: 1.4-1.8$ (1-2 months)-awaiting up listing approval, if not accepted then buyback at lower prices & use the Fib Retracement to better guide you.
Mind Medicine- Just to share a brief break down of what this company actually does. They are a research & drug development company focusing on LSD, Psilocybin, MDMA and a few other experimental drugs, CEO JR Rahn, Board of Directors Bruce Linton ( EX Canopy Founder) & Investors including Kevin O'leery AKA the dream team (just kidding).
Two major reasons behind the spike/growth in stock price. 1) They have submitted an application for an up listing onto the Nasdaq. 2) Compass Pathways also a Psilocybin company has IPO'd in the previous weeks & had been received very well by the markets/investors. Side Note: Marking a new wave of stocks of its kind (Shroom Boom)
Moving Forward: Since they are still in the drug & development stage, their financials are somewhat non-existent, so its quite difficult to put a price on this stock, but as we well all know markets are forward looking & the potential upside for this company could be exponential. Reason behind the logic for exponential growth is their drug pipeline, which is in the process of FDA approval, they currently have +5 drugs in the FDA approval process & with the shift into experimental drugs & their use in treating depression, anxiety, ADHD, PTSD, which in total is around a 100 billion dollar market. In simpler terms, the potential is there & the upside is there. Main question is: Will they get FDA approval for any of these 5 drugs in the pipeline? We have yet to wait & see. However, once they do up list onto the nasdaq expect to see average of a 20% surge in market prices.
Investment Decision: BUY, it is important to note than Mr.Benjamin Gram even once said keep 10-20% (depending how risk averse you are) in speculative positions. As a speculative buy, in my personal opinion this stock & the future potential that it may have in store for us is worth the buy. All it would take is one drug to be FDA approved. Even Amazon was once considered speculative.........
Target Price: 1.4-1.8$ (1-2 months)-awaiting up listing approval, if not accepted then buyback at lower prices & use the Fib Retracement to better guide you.
הערה
Target Reached
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.